Biosplice (was Samumed)
alternative splicing modulation, CLK/DYRK inhibition, Wnt pathway modulation
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
alternative splicing modulation, CLK/DYRK inhibition, Wnt pathway modulation
0-100 chain-logic scale · 15 dimensions · scored on public evidence
The 2011-02-07 Wayback snapshot for biosplice.com is a GoDaddy parked-domain landing page and does not contain any stated beliefs, mission, scientific position, or longevity-related theory from the company itself.
SourceThis Wayback snapshot shows a GoDaddy parked-domain landing page for biosplice.com rather than a company website, so it does not contain any stated beliefs, mission, or scientific/theoretical claims from the company.
SourceNo company beliefs, mission, or theory statements are visible in the provided snapshot text; the visible content is only the Internet Archive Wayback Machine header and crawl metadata.
SourceNo company beliefs, mission language, or scientific theories are visible in the provided snapshot text. The visible content is only Wayback Machine interface and archive metadata for biosplice.com, so no substantive company stance can be extracted from this capture as shown.
SourceThe company framed osteoarthritis as a large unmet medical need with no available drugs that arrest the disease, and presented its investigational program as a mechanistically targeted attempt to modify the disease rather than only manage symptoms. Its stated scientific stance centered on lorecivivint/SM04690 and Wnt-pathway modulation as a plausible way to improve pain and function while affecting underlying joint disease progression.
SourceThe company presented the view that regenerative capacity in adult tissues can be therapeutically influenced, and that controlling key developmental signaling pathways, especially Wnt, could restore or improve tissue repair in degenerative conditions. Its stated stance centered on using small-molecule modulation of these pathways to drive regeneration-oriented treatments rather than only managing symptoms.
SourceThe company’s stated position is that key regenerative signaling pathways, especially Wnt signaling, can be precisely modulated with small-molecule drugs to restore healthy tissue function and treat multiple degenerative or age-related conditions.
Source